Boston Scientific Corp (BSX) Key Ratios
$43.05
As on 17-Nov-2026 16:00EST
Market cap
$64,067 Mln
Revenue (TTM)
$21,069 Mln
P/E Ratio
18.6
P/B Ratio
2.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -5.59 | 1.44 | 8.88 | 15.27 | 12.93 |
| EBIT | -27.94 | -18.81 | 9.78 | 23.38 | 20.85 |
| Net Profit | -36.19 | -23.18 | 25.11 | 46.80 | 52.90 |
| EPS | -34.83 | -21.15 | 25.85 | 40.83 | 25.14 |
| Book Value | -- | -- | 10.90 | 9.96 | 8.77 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 16.80 | 15.01 | 19.13 | 18.60 | 15.94 |
| Net Margin
| -- | 7.06 | 16.56 | -- | -- |
| Return on equity
| 10.07 | 8.16 | 13.59 | 12.55 | 9.03 |
| Return on Capital
| 6.68 | 5.35 | -- | 8.30 | 6.01 |
| Return on Assets
| 5.55 | 4.42 | 7.02 | 6.95 | 4.98 |
| Debt to Equity (x)
| -- | -- | 0.42 | 0.51 | 0.51 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
8.30
|
6.01
|
5.73
|
2.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
13.59
Higher than Peers by 7.08
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
13.59
|
12.55
|
9.03
|
8.64
|
4.08
|
|
Peer Median
|
6.51
|
--
|
--
|
--
|
--
|
ROA
7.02
Higher than Peers by 4.05
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
7.02
|
6.95
|
4.98
|
4.71
|
2.16
|
|
Peer Median
|
2.96
|
--
|
--
|
--
|
--
|
EBIT Margin
19.13
Higher than Peers by 8.45
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
19.13
|
18.60
|
15.94
|
15.85
|
12.66
|
|
Peer Median
|
10.69
|
--
|
--
|
--
|
--
|
Net Margin
16.56
Higher than Peers by 9.57
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
16.56
|
14.38
|
11.07
|
11.19
|
5.52
|
|
Peer Median
|
6.99
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
8.88
Lower than Peers by 0.38
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
8.88
|
0.20
|
0.18
|
0.12
|
0.07
|
|
Peer Median
|
9.26
|
--
|
--
|
--
|
--
|
EBIT Growth
9.78
Lower than Peers by 2.99
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
9.78
|
39.90
|
18.25
|
40.62
|
12.63
|
|
Peer Median
|
12.76
|
--
|
--
|
--
|
--
|
Net Profit Growth
25.11
Higher than Peers by 11.28
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
25.11
|
55.66
|
16.38
|
128.22
|
-32.88
|
|
Peer Median
|
13.83
|
--
|
--
|
--
|
--
|
EPS Growth
25.85
Higher than Peers by 5.35
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
25.85
|
0.55
|
0.15
|
1.23
|
-0.33
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
12.84
Higher than Peers by 4.75
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
12.84
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.09
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.42
Higher than Peers by 0.05
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.42
|
0.51
|
0.51
|
0.49
|
0.53
|
|
Peer Median
|
0.37
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.04
|
0.02
|
0.08
|
0.03
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.36
Lower than Peers by 1.46
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
1.36
|
1.62
|
1.08
|
1.32
|
1.51
|
|
Peer Median
|
2.82
|
--
|
--
|
--
|
--
|
Quick Ratio
0.81
Lower than Peers by 1.28
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.81
|
1.08
|
0.64
|
0.82
|
1.02
|
|
Peer Median
|
2.09
|
--
|
--
|
--
|
--
|
Interest Coverage
10.72
Higher than Peers by 4.60
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
10.72
|
10.70
|
6.90
|
8.30
|
3.46
|
|
Peer Median
|
6.12
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.78
Lower than Peers by 1.65
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
14.78
|
14.58
|
15.27
|
15.65
|
15.53
|
|
Peer Median
|
16.42
|
--
|
--
|
--
|
--
|
Asset Turnover
0.42
Lower than Peers by 0.08
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
0.42
|
0.48
|
0.45
|
0.42
|
0.39
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
49.89
|
52.19
|
53.84
|
53.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
168.92
|
149.20
|
146.90
|
127.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
61.77
|
53.60
|
60.91
|
60.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
157.04
|
147.79
|
139.83
|
120.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
18.65
Lower than Peers by 27.51
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
18.65
|
49.42
|
71.79
|
53.60
|
95.62
|
|
Peer Median
|
46.16
|
--
|
--
|
--
|
--
|
Price / Book Value
2.55
Lower than Peers by 2.32
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
2.55
|
5.89
|
6.11
|
4.43
|
3.80
|
|
Peer Median
|
4.88
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
14.05
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
14.05
|
29.99
|
36.53
|
27.22
|
27.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
64,067
Higher than Peers by 63,402
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Boston Scientific Corp (BSX)
|
64,067
|
--
|
--
|
--
|
--
|
|
Peer Median
|
664
|
--
|
--
|
--
|
--
|